Acute liver failure is the rapid loss of liver function in someone who had no known liver disease beforehand, and it can progress from the first symptoms to life-threatening organ shutdown within days. Survival has improved dramatically over recent decades, climbing from roughly 20% to above 60%, thanks to better intensive care and the availability of emergency liver transplantation.1PubMed Central. Acute liver failure Despite that progress, the condition remains one of the most urgent scenarios in medicine, demanding rapid diagnosis, identification of the cause, and decisions about whether transplant is needed before the window closes.
What Causes Acute Liver Failure
The causes split roughly into a few major categories, and knowing which one is responsible changes almost everything about treatment and prognosis.
Acetaminophen Overdose
In North America and much of Europe, acetaminophen (paracetamol) toxicity is the single most common trigger. It does not take a deliberate overdose; stacking cold medications that each contain acetaminophen, or combining the drug with heavy alcohol use, can push doses into dangerous territory. When the liver metabolizes acetaminophen, a small fraction is converted into a reactive byproduct called NAPQI. Normally, the body’s stores of a protective molecule called glutathione neutralize NAPQI before it does harm. In overdose, glutathione gets used up, and NAPQI binds directly to proteins inside mitochondria, triggering a cascade of cell death.2PubMed Central. Mechanisms of acetaminophen hepatotoxicity and their translation to the human pathophysiology The good news is that this particular cause has a specific antidote, N-acetylcysteine, which works best when given early.
Drug-Induced and Herbal Supplement Injury
Prescription drugs, over-the-counter medications, and herbal or dietary supplements can all damage the liver severely enough to cause acute failure. This category is sometimes underappreciated because the products involved are marketed as safe or “natural.” A large systematic review of herb-induced liver injury found that about 7% of patients who needed medical intervention went on to develop acute liver failure requiring transplantation, and overall mortality across the reviewed cases was around 10%.3PubMed Central. Herb-induced liver injury: Systematic review and meta-analysis A study comparing herbal liver injury to conventional drug-induced injury found that the herbal group had higher rates of jaundice, encephalopathy, coagulopathy, and acute liver failure.4PubMed. Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury The takeaway is that “herbal” and “natural” labels do not guarantee liver safety, and unregulated supplements are a growing contributor to drug-induced liver injury worldwide.
Viral Hepatitis
Globally, viral hepatitis remains a leading cause, particularly in regions where hepatitis A, B, and E are endemic. In a U.S. registry that tracked acute liver failure patients, about 12% of all cases were caused by viral hepatitis, with hepatitis B accounting for the largest share and hepatitis A following behind.5PubMed. Viral hepatitis-related acute liver failure Hepatitis C, while a major cause of chronic liver disease, almost never produces fulminant acute failure. Hepatitis E, once considered a problem mainly in developing countries, has increasingly been recognized in Europe as well. Another scenario gaining clinical attention is the reactivation of hepatitis B in people receiving chemotherapy or other immune-suppressing treatments.6PubMed Central. Liver Failure due to Acute Viral Hepatitis (A-E)
Pregnancy-Related Causes
Two conditions unique to pregnancy can produce acute liver failure: acute fatty liver of pregnancy (AFLP) and HELLP syndrome (a combination of hemolysis, elevated liver enzymes, and low platelets). Both involve abnormal fat deposits in liver cells and share predisposing factors, including defects in how mitochondria process fatty acids and the added metabolic burden of carrying multiples. Distinguishing the two can be difficult, since their features overlap. AFLP tends to cause more pronounced jaundice and can progress rapidly to encephalopathy, whereas HELLP syndrome more often features high blood pressure and protein in the urine.7PubMed Central. HELLP Syndrome or Acute Fatty Liver of Pregnancy: A Differential Diagnostic Challenge: Common Features and Differences In one analysis of acute liver failure during pregnancy, roughly half of the pregnancy-specific cases were attributed to HELLP and half to AFLP, though some cases defied clear classification.8PubMed Central. Acute Liver Failure in Pregnancy: How Much Is Pregnancy Related? Delivery of the baby is the definitive treatment for both.
What Happens to the Brain
One of the most feared complications of acute liver failure is what happens inside the skull. When the liver stops functioning, it can no longer clear ammonia and other toxins from the blood. Ammonia accumulates and crosses into the brain, where it disrupts the function of astrocytes, the cells that support neurons. This process drives hepatic encephalopathy, a spectrum that ranges from subtle confusion and personality changes to deep coma.9PubMed Central. Hyperammonemia in Hepatic Encephalopathy In its more severe forms, ammonia-driven brain swelling (cerebral edema) can raise pressure inside the skull to dangerous levels, potentially causing herniation, which is fatal without intervention.
Managing brain swelling is a critical piece of intensive care for these patients. Options include hypertonic saline and mannitol to draw fluid out of brain tissue, controlled cooling of body temperature, and sedation with propofol, all of which can lower intracranial pressure and buy time.10PubMed. Assessment and management of cerebral edema and intracranial hypertension in acute liver failure In patients with advanced encephalopathy (grade III or IV), monitoring intracranial pressure directly with a sensor gives the medical team real-time data to guide these treatments. The goal is to keep the brain alive and intact while the liver either recovers on its own or a transplant organ becomes available.
The Paradox of Bleeding and Clotting
Standard blood tests in acute liver failure look alarming. The INR, a common measure of clotting ability, shoots up because the liver has stopped producing many of the proteins the blood needs to form clots. For years, clinicians assumed this meant patients were at extreme risk of bleeding and reflexively gave blood products to “correct” the numbers. The reality turned out to be more nuanced.
The liver makes both the proteins that promote clotting and the ones that restrain it. In acute liver failure, production of both sides drops together, creating a fragile but surprisingly functional balance. Elevated von Willebrand factor and procoagulant microparticles from platelets partially compensate for deficiencies elsewhere in the system.11PubMed. Rebalanced Hemostasis in Patients with Acute Liver Failure Laboratory testing that accounts for both sides of the equation, rather than just the procoagulant side, shows that the overall clotting potential can be essentially normal.12PubMed. Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation
This “rebalanced hemostasis” concept matters practically. It means that a high INR number alone does not tell you whether the patient will bleed, and aggressively giving clotting products may actually tip the balance toward dangerous clot formation rather than preventing hemorrhage.13PubMed Central. Clinical Considerations of Coagulopathy in Acute Liver Failure The balance is unstable, though, and any additional insult, whether infection, surgery, or an invasive procedure, can push it in either direction. Clinicians have increasingly moved toward a strategy of correcting coagulation only when there is active bleeding or a high-risk procedure is planned, rather than chasing a normal-looking INR.
Systemic Inflammation and Infection
Acute liver failure does not stay confined to the liver. The massive cell death releases inflammatory signals that can set off a body-wide inflammatory response resembling sepsis, even before any actual infection sets in. In a large study of nearly 900 patients admitted for acute liver failure at a single center over 11 years, about 57% developed a systemic inflammatory response during their illness, and those who were also infected developed more severe inflammatory responses.14PubMed. The systemic inflammatory response syndrome in acute liver failure This inflammation contributes to kidney failure, circulatory collapse, and worsening brain swelling. Because the immune system is simultaneously weakened by the loss of liver-produced immune proteins, patients are caught in a cruel double bind: an exaggerated inflammatory response alongside reduced ability to fight off infections. Surveillance cultures and a low threshold for starting antibiotics are standard practice in the intensive care unit for these patients.
N-Acetylcysteine Beyond Acetaminophen
N-acetylcysteine (NAC) has long been the established antidote for acetaminophen poisoning, where it replenishes glutathione and helps the liver neutralize the toxic metabolite NAPQI. What has generated interest more recently is whether NAC helps in acute liver failure caused by something other than acetaminophen. The evidence suggests it does, at least modestly.
A meta-analysis found that patients given NAC for non-acetaminophen acute liver failure had nearly triple the odds of surviving without needing a transplant compared to controls, and post-transplant survival also improved.15PubMed Central. Role of N-acetylcysteine in non-acetaminophen-related acute liver failure: an updated meta-analysis and systematic review A separate meta-analysis focusing on prospective studies confirmed improved transplant-free survival (roughly 55% vs. 28% in controls) and shorter hospital stays, though the improvement in overall survival did not reach statistical significance in that particular analysis.16PubMed Central. N-acetylcysteine in non-acetaminophen-induced acute liver failure: a systematic review and meta-analysis of prospective studies An individual prospective trial showed a drop in mortality from 53% to 28% with NAC use, with the benefit appearing strongest in drug-induced cases.17PubMed Central. Role of N-acetylcysteine treatment in non-acetaminophen-induced acute liver failure: A prospective study The mechanism in non-acetaminophen cases is not fully understood; NAC may help by improving blood flow to the liver, scavenging damaging free radicals, or modulating the inflammatory response. Either way, many centers now give it routinely in the early stages of acute liver failure regardless of the cause.
Plasma Exchange as a Bridge
When the liver fails catastrophically, toxic substances accumulate in the blood faster than any medication can clear them. Therapeutic plasma exchange (TPE) physically removes the patient’s plasma and replaces it with donor plasma, effectively washing out toxins, inflammatory mediators, and damaged clotting factors in one sweep. High-volume TPE has been shown to reduce the need for drugs that support blood pressure and improve survival, particularly in patients who are not candidates for transplantation.18PubMed Central. Therapeutic plasma exchange in liver failure
In patients who are transplant candidates, plasma exchange serves a different but equally important role: it can stabilize a deteriorating patient long enough for a donor organ to be found. A systematic review noted that plasma exchange temporarily stabilized patients before transplant, buying the critical hours or days needed to source a donor liver.19PubMed Central. Plasma exchange in patients with acute and acute-on-chronic liver failure: A systematic review Case reports have even documented complete recovery without transplant after sequential use of high-volume plasma exchange and continuous kidney-support therapy in patients who had no transplant option available.20PubMed Central. Sequential Use of High-Volume Plasma Exchange and Continuous Renal Replacement Therapy in Hepatitis B Virus-Related Acute Liver Failure: A Case Report Plasma exchange is not a replacement for transplantation, but it has become an increasingly valued tool in the armamentarium for keeping patients alive until the liver either regenerates or a graft arrives.
Deciding Who Needs a Transplant
The hardest clinical decision in acute liver failure is whether to list someone for emergency transplantation. List too early and you commit a patient to lifelong immunosuppression who might have recovered on their own. List too late and they die waiting. Two scoring systems have been used for decades to help with this call.
The King’s College Criteria (KCC), developed in the late 1980s, use a set of clinical and laboratory thresholds, different depending on whether the cause is acetaminophen or something else, to predict who will not survive without a transplant. A meta-analysis found that the KCC more accurately predict hospital mortality in acetaminophen-induced cases, while the MELD score (a numerical system originally designed for chronic liver disease) performs better in non-acetaminophen cases.21PubMed. Ability of King’s College Criteria and Model for End-Stage Liver Disease Scores to Predict Mortality of Patients With Acute Liver Failure: A Meta-analysis Neither system is perfect. The KCC have good specificity, meaning that when they say someone will die without a transplant, they are usually right. But their sensitivity is more limited, meaning they miss some patients who also needed a transplant.22PubMed. Meta-analysis of performance of Kings’s College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure That same analysis found that improvements in modern intensive care may have changed the KCC’s predictive performance over time, since outcomes in general have improved since the criteria were originally validated.
In practical terms, neither scoring system alone dictates the decision. Teams evaluate the trajectory of laboratory values, the degree of encephalopathy, the cause of failure, and the patient’s overall clinical picture. Patients with advanced encephalopathy who meet the criteria get listed urgently. One study evaluating transplant listing criteria found that in patients with severe encephalopathy at admission, the criteria were reliable for identifying who would not survive, but in patients with milder encephalopathy, there was more room for watchful waiting.23Journal of Hepatology. Emergency liver transplantation for acute liver failure: Evaluation of London and Clichy criteria
What Emergency Transplantation Looks Like
Emergency liver transplantation for acute liver failure is a different animal from the planned transplants performed for chronic liver disease. The timeline is compressed to days rather than months. In one long-term study spanning 13 years, the average wait from listing to surgery was just 2.7 days, and 6% of those listed died before a donor organ arrived.24PubMed. Long-term outcomes of emergency liver transplantation for acute liver failure After transplantation, the perioperative mortality rate was 15%, with neurological complications (largely a consequence of the pre-transplant brain injury), biliary problems, and hepatic artery clotting as the main post-surgical risks. Long-term outcomes were encouraging: five-year survival was 76% and ten-year survival was 69%. Patients who had cerebral edema before transplant or who received organs from extended-criteria donors had worse outcomes.
These numbers are important context for understanding why the transplant decision is so weighty. You are asking someone who was healthy days ago to undergo major surgery and accept a lifetime of anti-rejection medications, but you are also offering them a roughly three-in-four chance of being alive five years later, in a condition that was nearly universally fatal before transplantation became available.
The Liver’s Capacity to Regenerate
Unlike most organs, the liver can rebuild itself after massive injury. In acute liver failure, if enough hepatocytes (the liver’s main working cells) survive the initial insult, they can replicate to restore the organ’s mass and function.25PubMed Central. Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations This is the biological basis for “transplant-free survival,” the scenario every clinician hopes for. When a patient with acute liver failure survives without a new organ, it is because their own liver regenerated quickly enough to keep up with the body’s demands.
The likelihood of spontaneous recovery depends heavily on the cause. Acetaminophen-related failure, despite often looking catastrophic on lab tests, has a relatively high rate of recovery without transplant, in part because the injury is a single, time-limited insult and the drug can be cleared from the body. Viral causes and drug reactions are more variable. Wilson disease and certain metabolic causes almost never recover without transplant. This variation is one reason clinicians cannot rely solely on how sick someone looks at a single point in time; they need to know the cause and then watch the trend over hours and days.
Acute Liver Failure in Children
The causes of acute liver failure in children differ substantially from adults. While acetaminophen and viral hepatitis still appear, metabolic and genetic diseases play a much larger role. Conditions like Wilson disease can cause acute liver failure in teenagers, while mitochondrial disorders tend to strike infants.26Trends in Molecular Medicine. Mechanisms of pediatric acute liver failure A study from Saudi Arabia found that after indeterminate causes (which made up about 46% of pediatric cases), genetic-metabolic diseases and drug-induced injury were the most common identifiable triggers.27PubMed. Pediatric acute liver failure in Saudi Arabia: prognostic indicators, outcomes and the role of genetic testing In that cohort, genetic testing identified a specific disease-causing mutation in about one in five of the children tested, underscoring how frequently pediatric acute liver failure has an underlying inherited component that would be missed without specific workup.
A particularly frustrating reality in pediatric acute liver failure is the large proportion of cases classified as “indeterminate,” meaning no cause is identified despite extensive testing. This percentage is higher in children than in adults, and it complicates both treatment decisions and genetic counseling for families. Ongoing advances in rapid whole-genome and whole-exome sequencing are beginning to chip away at this unknown category, but it remains a significant gap.
Life After Survival
Surviving acute liver failure, whether through spontaneous recovery or transplantation, is not the end of the story. A study comparing long-term quality of life in survivors found that they reported significantly lower general health scores and more days of impaired mental and physical health than the general U.S. population.28PubMed Central. Quality of life is significantly impaired in long-term survivors of acute liver failure and particularly in acetaminophen-overdose patients The impact was most pronounced in those whose acute liver failure was caused by intentional acetaminophen overdose. That group had higher rates of pre-existing psychiatric illness and substance use disorders, and they reported more pain, depression, anxiety, and activity limitations than survivors whose liver failure had other causes. The severity of the acute illness itself, measured by things like coma grade or use of mechanical ventilation, did not differ between the groups. This suggests that the poor quality of life in acetaminophen-overdose survivors is driven more by the underlying psychiatric and psychosocial factors that led to the overdose than by the liver failure itself.
For transplant recipients, the ongoing demands of immunosuppressive medication, regular monitoring, and the psychological weight of having almost died create their own set of challenges. Post-transplant patients report a general improvement in well-being compared to their acute illness, but they do not return to the quality of life of the general population. The combination of physical recovery, medication side effects, and the emotional aftermath of a near-death experience means that comprehensive follow-up, including mental health support, should be standard care rather than an afterthought.